XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   112,639,146    
Beginning balance at Dec. 31, 2023 $ 482,597,000 $ 113,000 $ 1,267,469,000 $ (784,985,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (40,527,000)     (40,527,000)
Exercise of stock options (in shares) 1,028,184 1,028,184    
Exercise of stock options $ 5,404,000 $ 1,000 5,403,000  
Issuance of common stock related to Spyce milestone achievement 2,132,000      
Issuance of common stock related to Spyce milestone achievement (in shares)   208,042    
Issuance of common stock related to restricted shares (in shares)   264,346    
Shares repurchased for employee tax withholding (in shares)   (186)    
Shares repurchased for employee tax withholding 0   0  
Stock-based compensation expense 20,529,000   20,529,000  
Ending balance (in shares) at Jun. 30, 2024   114,139,532    
Ending balance at Jun. 30, 2024 470,135,000 $ 114,000 1,295,533,000 (825,512,000)
Beginning balance (in shares) at Mar. 31, 2024   113,209,760    
Beginning balance at Mar. 31, 2024 470,278,000 $ 113,000 1,281,217,000 (811,052,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (14,460,000)     (14,460,000)
Exercise of stock options (in shares)   770,983    
Exercise of stock options $ 3,414,000 $ 1,000 3,413,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   158,975    
Shares repurchased for employee tax withholding (in shares) (186)      
Shares repurchased for employee tax withholding $ 0      
Stock-based compensation expense 10,903,000   10,903,000  
Ending balance (in shares) at Jun. 30, 2024   114,139,532    
Ending balance at Jun. 30, 2024 470,135,000 $ 114,000 1,295,533,000 (825,512,000)
Beginning balance (in shares) at Dec. 29, 2024   117,116,311    
Beginning balance at Dec. 29, 2024 446,145,000 $ 117,000 1,321,386,000 (875,358,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (48,197,000)     (48,197,000)
Exercise of stock options (in shares) 323,369 323,369    
Exercise of stock options $ 2,679,000 $ 1,000 2,678,000  
Issuance of common stock related to Spyce milestone achievement 4,709,000      
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Issuance of common stock related to restricted shares (in shares)   524,848    
Shares repurchased for employee tax withholding (in shares)   (9,745)    
Shares repurchased for employee tax withholding (259,000)   (259,000)  
Stock-based compensation expense 18,221,000   18,221,000  
Ending balance (in shares) at Jun. 29, 2025   118,197,505    
Ending balance at Jun. 29, 2025 423,298,000 $ 118,000 1,346,735,000 (923,555,000)
Beginning balance (in shares) at Mar. 30, 2025   117,658,484    
Beginning balance at Mar. 30, 2025 432,754,000 $ 118,000 1,333,033,000 (900,397,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (23,158,000)     (23,158,000)
Exercise of stock options (in shares)   112,661    
Exercise of stock options 996,000   996,000  
Issuance of common stock related to Spyce milestone achievement 4,709,000   4,709,000  
Issuance of common stock related to restricted shares (in shares)   183,732    
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Shares repurchased for employee tax withholding (in shares)   (94)    
Shares repurchased for employee tax withholding (3,000)   (3,000)  
Stock-based compensation expense 8,000,000   8,000,000  
Ending balance (in shares) at Jun. 29, 2025   118,197,505    
Ending balance at Jun. 29, 2025 $ 423,298,000 $ 118,000 $ 1,346,735,000 $ (923,555,000)